Lung Health Institute

The Lung Health Institute was a network of medical clinics specializing in regenerative medicine for chronic respiratory conditions. Founded in 2013, the company offered autologous stem cell therapies, which involved harvesting a patient's own cells from their blood or bone marrow and reintroducing them to target lung inflammation. The institute operated several locations across the United States, marketing its services primarily to patients with COPD and pulmonary fibrosis. However, the company faced significant scrutiny from the medical community and regulatory bodies for offering unproven treatments without FDA approval or rigorous clinical trial evidence. As of the early 2020s, the company has ceased operations and closed its clinical locations.